NICE heads into its May 14 Q1 2026 results on deeply damaged ground — the question is whether the print accelerates a recovery or extends a brutal de-rating.
The stock has lost 29% in a single week, with a 4% drop on Monday alone, still absorbing the aftermath of the prior Q4 print on May 6 when shares fell more than 20% in one session. That reaction was one of the sharpest single-day moves the stock has seen in recent memory, and NICE has clawed back little of the damage. Year-to-date, it is now off almost 18%. Despite the violent price action, the lending market remains notably relaxed. Cost to borrow is running below 1%, and borrow availability is comfortable — positioning suggests short sellers have not yet piled in aggressively in response to the selloff. The ORTEX short score of around 43-44 is moderate, well below levels that would signal crowded short positioning.
Analysts have responded to the May 6 collapse by trimming targets across the board, but the direction-of-travel is important: none of the recent movers pulled their bullish ratings. Morgan Stanley reiterated Overweight but cut its target to $130. RBC Capital held Outperform with a new $130 target. Citizens retained Market Outperform at $170. Citi maintained Neutral and dropped its target to $100. The consensus still implies roughly 49% upside to current levels — a figure that reflects how far the stock has fallen rather than any surge of fresh conviction. The analyst community is telling investors the selloff was overdone while simultaneously acknowledging the near-term picture has deteriorated. The RSI-14 at 38 puts the stock in technically oversold territory, adding a technical dimension to the bull case.
The institutional picture shows Principal Global Investors as the largest holder, reporting a near-doubling of its stake as recently as April 30 — just before the earnings shock. That filing captured accumulation ahead of a print that ultimately punished buyers. Principal's position is now materially underwater on that added exposure. BlackRock also added modestly in April. The earnings history provides a sharp contrast: the February 2026 Q4 print produced a 20% gain in a single session, one of the best reactions in recent quarters; the May print produced the mirror image. NICE has demonstrated it can swing violently in both directions around results.
Thursday's print is fundamentally a test of whether the guidance cut embedded in May's collapse was conservative or whether a further step-down is coming — and whether management's AI-driven contact-centre narrative can reassert itself against a backdrop of intense scepticism.
See the live data behind this article on ORTEX.
Open NICE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
